Perspective: Targeting the JAK/STAT pathway to fight age-related dysfunction

Area of Science:

• Cellular and Molecular Biology
• Gerontology
• Immunology

Background:

• Cellular senescence is a state of irreversible growth arrest that accumulates in tissues with age.
• Senescent cells exhibit a senescence-associated secretory phenotype (SASP), releasing inflammatory factors that disrupt tissue homeostasis.
• The SASP contributes to age-related local and systemic dysfunction.

Purpose of the Study:

• To investigate the role of the JAK pathway in regulating the SASP.
• To determine if JAK pathway inhibition can mitigate the negative effects of cellular senescence.

Main Methods:

• Analysis of JAK pathway activation in senescent versus non-senescent cells.
• Assessment of SASP component secretion following JAK pathway inhibition.
• Evaluation of tissue function and age-related dysfunction markers after JAK inhibition.

Main Results:

• The JAK pathway demonstrates heightened activation in senescent cells compared to non-senescent cells.
• Inhibition of the JAK pathway effectively suppresses the SASP in senescent cells.
• Targeting the JAK pathway alleviates age-related tissue dysfunction.

Conclusions:

• The JAK pathway is a key regulator of the SASP in senescent cells.
• JAK pathway inhibition represents a potential therapeutic strategy to combat age-related tissue dysfunction.
• Targeting senescent cells via JAK inhibition may improve healthspan in aging populations.